Hernia Clinical Trial
Official title:
Opioid Use, Storage, and Disposal Among Pediatric Patients After Surgery
Opioids are an important component of post-operative pain management among children, but are often prescribed in excess and rarely disposed of appropriately. The lack of prompt and proper opioid disposal after recovery from surgery is contributing to the opioid crisis in Ohio by placing children at risk of accidental ingestion of opioids remaining in the home and allowing for unused opioids to be diverted for non-medical use. The investigators propose to reduce the burden of the opioid crisis in Ohio by testing a strategy to increase proper opioid disposal by families of children undergoing outpatient surgery. The investigators will test the impact of a novel opioid disposal mechanism, the Deterra® drug deactivation system, after pediatric surgical operations. This system deactivates pills, liquids, or patches, allowing for their disposal in the home garbage. The investigators propose to evaluate the effectiveness of providing Deterra® bags to families of children having surgery on their disposal of excess opioids. The investigators will perform a randomized controlled trial (RCT) to test the effectiveness of Deterra® to improve opioid disposal among families of children having outpatient surgery at Nationwide Children's Hospital.
Opioids are an important component of post-operative pain management among children, but are
often prescribed in excess and rarely disposed of appropriately. The lack of prompt and
proper opioid disposal after recovery from surgery is contributing to the opioid crisis in
Ohio by placing children at risk of accidental ingestion of opioids remaining in the home and
allowing for unused opioids to be diverted for non-medical use. The investigators propose to
reduce the burden of the opioid crisis in Ohio by testing a strategy to increase proper
opioid disposal by families of children undergoing outpatient surgery. The investigators will
test the impact of a novel opioid disposal mechanism, the Deterra® drug deactivation system,
after pediatric surgical operations. This system deactivates pills, liquids, or patches,
allowing for their disposal in the home garbage. The investigators propose to evaluate the
effectiveness of Deterra® for opioid disposal among families of Ohio children having surgery.
The investigators will perform a randomized controlled trial (RCT) to test the effectiveness
of Deterra® to improve proper opioid disposal among families of children having outpatient
surgery at Nationwide Children's Hospital.
The goal of this project is to evaluate the impact of providing the Deterra® drug
deactivation system on the excess opioid disposal rate among families of children having
outpatient otolaryngologic or urologic surgery at NCH. A second objective of this study is to
evaluate whether the impact of the Deterra® drug deactivation system varies by
parent/guardian health literacy level or signing of an "opioid consent form" acknowledging
that they will follow appropriate dosing recommendations, not give opioids if their child
appears sleepy, not give Tylenol concurrently with Tylenol-containing opioid medications,
dispose of unused opioids safely and responsibly, and contact their child's surgeon's office
or the on-call physician with any questions. To accomplish these objectives, the
investigators will perform a randomized controlled trial comparing groups of patients who
receive either 1) a Deterra® bag along with brief instruction on how and why to use it along
with routine postoperative instructions or 2) routine postoperative instructions.
The investigators plan to enroll 202 caregivers of children having outpatient surgery. All
families will receive a 1-page pain journal to record the child's opioid and non-opioid
adjunct pain medication administration. In addition to the instructions provided by the care
team as described above, families randomized to the intervention arm will additionally
receive a Deterra® bag and instructions on its use by a research team member.
In order to minimize disruption to the clinical work flow, minimal data will be collected at
baseline directly from enrolled families. This will include the contact information required
for follow-up, a limited set of research related questions, and a brief assessment of
parent/guardian health literacy. Baseline demographic and clinical characteristics of the
child, such as their primary payer, residential address, age, and comorbidities at the time
of surgery will be extracted from the electronic medical record.
Parents/guardians will be contacted by their preferred method of email survey or phone call
at 2 weeks postoperatively, at which time they will be surveyed on their child's
postoperative opioid and non-opioid medication use, opioid storage location, quantity of
opioid remaining, disposal method, and any barriers to disposal. If the child continues to
require opioids, they will be contacted again at 4 weeks postoperatively. If the parent
believes that their older child or adolescent can assist in answering the survey questions,
they will be encouraged to complete the survey together. The primary outcome of this trial is
the proper disposal of unused opioids. Secondary outcomes include the quantities of opioid
used and leftover after surgery, opioid storage location, disposal by any method, and
barriers to disposal.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01629485 -
Part vs Whole Task Mastery Training for Laparoscopic Hernia Repair
|
N/A | |
Terminated |
NCT01305486 -
A Study of Complex Ventral Hernia Repair Utilizing the XenMatrix™ Surgical Graft With Component Separation
|
N/A | |
Completed |
NCT01205399 -
A Retrospective Study With Prospective Follow-Up of Complex Ventral Hernia Repair Utilizing the AlloMax Surgical Graft
|
N/A | |
Completed |
NCT00905320 -
Hernia Repair With or Without Sutures
|
N/A | |
Completed |
NCT01141335 -
Polypropylene Mesh Versus Polytetrafluoroethylene (PTFE) Mesh in Inguinal Hernia Repair
|
Phase 4 | |
Completed |
NCT00617357 -
Repair of Infected or Contaminated Hernias
|
N/A | |
Completed |
NCT00535990 -
Minimally Invasive Surgery (MIS) Database for the Purpose of Research
|
||
Withdrawn |
NCT00138957 -
Study of a New Laparoscopic Technique for Parastomal Hernia Repair With Mesh
|
N/A | |
Completed |
NCT06034652 -
T-GENVIH-003 LTFU (Long Term Follow Up) Study
|
||
Completed |
NCT06389331 -
Study on Effects of Defect Closure in Laparoscopic Repair of Direct Inguinal Hernia
|
||
Completed |
NCT04119466 -
Stabilizing Training in Degenerative Disc Disease
|
N/A | |
Completed |
NCT00622583 -
International Hernia Mesh Registry
|
||
Completed |
NCT04137172 -
Short Term Outcomes of Laparoscopic Intraperitoneal Onlay Mesh With Facial Repair(IPOM-plus) for Ventral Hernia.
|
N/A | |
Completed |
NCT01132209 -
Suture Techniques to Reduce the Incidence of The inCisional Hernia
|
N/A | |
Completed |
NCT00032448 -
Does Tension-Free Herniorrhaphy or Laparoscopic Herniorrhaphy Achieve Equal or Better Recurrence Rates and Lower Costs While Achieving Equivalent Outcomes for Hernia Patients?
|
Phase 3 | |
Not yet recruiting |
NCT05061589 -
Incidence and Risk Factors of Parastomal Hernia in Patients With Permanent Colostomy in China
|
||
Active, not recruiting |
NCT02439060 -
PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)
|
N/A | |
Completed |
NCT02238964 -
Reinforcement of Closure of Stoma Site
|
Phase 2/Phase 3 | |
Completed |
NCT01727388 -
Informativeness to Digital Rectal Examination
|
Phase 3 | |
Completed |
NCT01997619 -
Biological Mesh Repair of Complex Hernias in High Risk Patients
|
N/A |